Certified by Founder Lodge
Motive Ventures
United States - New York
INVESTOR
1 Disclosed Funding Rounds $28,000,000
11 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Motive Ventures is the early-stage investment arm of Motive Partners, focused on pre-seed through to Series A financial technology investments in North America and Europe (incl. Israel). Moti
| Company | Date | Round | Raised |
|---|---|---|---|
Pliant |
February, 22 ,2023 | Series A | $28,000,000 |
TRIVER |
April, 21 ,2023 | Unknown | $8,674,000 |
TIFIN |
June, 09 ,2023 | Series A | |
Nelly |
June, 15 ,2023 | Series A | $16,311,450 |
Vega |
September, 27 ,2023 | Unknown | $8,000,000 |
Korr |
January, 12 ,2024 | Seed | $3,200,000 |
bezahl.de (NX Technologies GmbH) |
March, 22 ,2024 | Series B | $23,811,370 |
alphastream.ai |
May, 07 ,2024 | Seed | |
MYNE |
August, 01 ,2024 | Series A | $43,151,400 |
Nelly Solutions |
January, 15 ,2025 | Series B | $51,555,959 |
Zocks | AI for Advisors |
March, 12 ,2025 | Series A | $13,800,000 |
Pliant
TRIVER
TIFIN
Nelly
Vega
Korr
bezahl.de (NX Technologies GmbH)
alphastream.ai
MYNE
Nelly Solutions
Zocks | AI for Advisors
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)